Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,589 total articles
MasterBrand completed the $3.6B acquisition of American Woodmark on 05/29/2026. The combined company trades at just ~0.41x price-to-sales and an EV/EBITDA around 11.4x today. With solid liquidity (current ratio 2.08), moderate leverage (debt/equity 0.82) and free cash flow generation, this setup offers a constructive risk-reward for a long trade si…
Dell's latest report rewrites the narrative: $24.4B in new AI orders, a $51.3B AI server backlog and raised FY27 revenue targets underpin a tradeable momentum setup. Technicals are stretched but institutional demand and short-covering make a disciplined long with a $421.10 entry, $360 stop and $520 target a pragmatic swing idea.
Molson Coors trades like a broken brewer: cheap on textbook metrics, generating meaningful free cash flow, and offering a 4.8% yield while sentiment and volume trends look soft. We upgrade to a long trade with a $50 target and a $36 stop, targeting a reposition into an industry leader ahead of demand catalysts and potential industry consolidation.
Alcon is trading near $66 after a product and portfolio reset that, in our view, sets the stage for margin recovery and steady top-line growth. Balance-sheet strength, modest leverage and a $33B market cap make the risk/reward attractive. We initiate a buy with a clear entry, stop and target and a long-term horizon to let the multi-quarter recovery…
InterContinental Hotels Group (IHG) is trading near its 52-week high after a sustained recovery in revenue and profits, improving technicals, and a visible strategy to expand in high-growth markets. With a market cap of roughly $23.1B and a PE of 31.5, the stock looks priced for continued execution but not fully stretched. This trade idea proposes …
Rocket Lab ($143.54) is trading as a prime SpaceX-proxy after a massive run from its 52-week low. ETF inflows, a $2.2B backlog in space systems, and new defense wins are driving momentum even as traditional valuation metrics look stretched. This is a tactical long trade that leans on continued sector rotation ahead of the SpaceX IPO and near-term c…
Xunlei posted accelerating revenue growth and holds more than $300M in cash against a $381M market cap. Recent technicals show constructive price action around the 20-50 day averages. This trade idea outlines an entry at $6.05, stop at $5.25 and target at $8.50 over a mid-term (45 trading days) horizon, with clear catalysts and risk controls.
Palantir's recent selloff reset expectations and handed buyers a cleaner entry. At $156.59 Palantir still trades at a premium, but improving commercial traction, a growing defense tailwind, and healthy free cash flow create an asymmetric trade if risk is controlled. This idea outlines a long trade with precise entry, stop and target, plus catalysts…
Mistras Group provides non-destructive testing, monitoring and integrity solutions to oil & gas and other heavy industries. With oil & gas production elevated and pipeline integrity budgets rising, Mistras stands to see renewed demand for inline inspection, crack-detection sensors and services. The company trades at a reasonable EV/EBITDA and P/S g…
Coupang's headline risk from a 34M-account data breach has been absorbed by the market. With revenue momentum returning, positive free cash flow, a reasonable EV/Sales of 0.73 and technicals beginning to improve, the risk/reward favors a bullish swing trade. This idea lays out an entry, stop and target with clear catalysts and what would make us ch…
SharpLink (SBET) offers concentrated exposure to Ethereum through an institutional treasury. With a market cap of ~$1.205B and reported holdings of 868,699 ETH, the stock currently trades at a steep discount to the implied value of its crypto reserve. This trade idea buys that disconnect, with clear entry, stop and target and a plan that spans cata…
Carnival (CCL) looks set to grind higher as record bookings and improving free cash flow offset near-term fuel pressure. Valuation at ~12.6x earnings and an EV/EBITDA of ~8.5 offers a margin of safety. This is a tactical long for traders who want exposure to travel recovery with a defined stop and clear catalyst runway.
Epsilon Energy just closed a Powder River Basin acquisition and expanded its credit capacity while continuing to pay a 4%+ yield. At $5.66 the stock trades at attractive free-cash-flow multiples and an EV/EBITDA around 7.7. This trade targets a mid-term re-rating as production and FCF from newly acquired oil assets come online, with a clear entry, …
Xeris Biopharma reported a 48.8% jump in Q2 2025 revenue and raised guidance. At a $1.06B market cap and EV of $1.17B, current multiples assume near-perfect execution. If Recorlev and Gvoke/Ogluo keep growing and FCF expands, the stock could double from $6.16. This trade idea lays out an entry, stop, targets, catalysts and the key risks to the bull…
Hess Midstream (HESM) is trading around $37.50 and yields roughly 8% from a quarterly distribution of $0.7792. The partnership's concentrated exposure to the Bakken and a long-term commercial tie to Chevron give it predictable throughput and cash flow. With EV/EBITDA near 7.0 and free cash flow approaching $796 million, HESM offers an asymmetric in…
Erdene Resource Development is a Mongolia-focused explorer/developer that the market appears to be underweight. The company's near-term catalysts - drilling updates, resource growth potential, and project de-risking steps - could re-rate the stock well above current levels. This trade idea outlines an actionable long with a clear entry, stop and ta…
<p>Stablecoins are becoming the plumbing of crypto finance. Circle sits at the center of the largest regulated dollar-pegged stablecoin ecosystem and, in my view, is positioned to capture disproportionate fees, float income, and product expansion as tokenized dollars become ubiquitous. Public financial detail for Circle is limited; this trade is a …
Carlyle trades near its 52-week low while key fundamentals - $1.48B in free cash flow, a 14% ROE and an EV/EBITDA of 8.8 - argue for upside. Limited direct exposure to the stressed parts of the private credit market, ongoing strategic M&A and securitization activity, plus a 3.1% yield make CG a pragmatic long over the next 180 trading days.
LKQ is trading near $27 with an enterprise value of ~$10.4B, EV/EBITDA of 7x and free cash flow of $808M. The combination of solid cash generation, a 4.4% yield and a potential legal resolution/clarity in June makes the stock attractive for a defined-risk long trade over the next 180 trading days.
General Motors checks several boxes investors care about: robust free cash flow ($14.8B trailing), a reasonable EV/EBITDA (10.7), cheap price-to-sales (0.41) and a concrete near-term demand opportunity as a rival’s truck inventory tightens. This trade targets a measured mid-term bounce fueled by margin-accretive ICE truck investments and share gain…
ConocoPhillips (COP) is an actionable buy after the recent pullback. Strong Q1 results, a 30-year Alaska LNG sales agreement and robust free cash flow position the company to capitalize on higher hydrocarbon prices and project optionality. Enter at $112.65, stop at $101.00, target $138.00 over a long-term horizon (180 trading days).
Super Micro (SMCI) is trading like an AI-server story, but recent moves around compliance, a European GPU cloud partnership, and an expanding product set suggest the company could evolve into a broader AI infrastructure platform. Valuation is reasonable at about $27.7B market cap and EV/sales near 1.0, offering asymmetric upside if execution contin…
Evolution Petroleum pays a rich ~11% yield but trades with negative EPS, negative free cash flow, and moving averages sitting above the stock. With ex-dividend on 06/15/2026 and weak technical momentum, this is a tactical short for traders who want to sell a measured bounce toward the $4.50 area. Entry, stop and target included with a mid-term (45 …
Dianthus (DNTH) is a clinical-stage monoclonal antibody company riding positive Phase 3 momentum for claseprubart and an expanding autoimmune pipeline. The stock trades near $93 with a market cap around $5.1B; recent financing and institutional interest reduce near-term liquidity risk while leaving a clear binary readthrough from ongoing trials. Th…
Rumble's planned acquisition of Northern Data and early monetization of cloud and Shorts features create a credible path from a video platform to an AI infrastructure and monetization play. The stock is richly valued on current revenue but the combination gives operational leverage via owned GPU capacity and a $100M advertising commitment that supp…
